TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS Russian patent published in 2023 - IPC C07D417/14 C07D401/14 C07D403/14 A61K31/4725 A61P35/00 

Abstract RU 2797244 C2

FIELD: medicinal chemistry.

SUBSTANCE: bifunctional compounds used as modulators of the estrogen receptor (target protein). In particular, the present invention relates to bifunctional compounds having the chemical structure ULM-L-PTM, which contain at one end a ligand that binds to E3 ubiquitin ligase, and at the other end a fragment that binds to the target protein so that the target protein is located in the immediate vicinity of the ubiquitin ligase, with the implementation of destruction and inhibition of the target protein. In the general formula ULM-L-PTM: ULM is the chemical structure (a), W is selected from the group consisting of CH2, CHR and C=O; each X is O; Z is O; G is H; Q1, Q2, Q3 and Q4 are independently N or C independently substituted with R or H; A is H or linear or branched C1-6 alkyl; n is 1, 2 or 3; each R is independently selected from -OR', -NR'R", -CR'R"-, 6-membered aryl, 5- or 6-membered heteroaryl with one or two heteroatoms, linear or branched C1-6alkyl, C3-7cycloalkyl, C3-7heterocyclyl with one, two or three heteroatoms, where one R is covalent-bonded to L; R' and R'' independently represent a bond or H; and is a bond that may or may not provide a stereospecific configuration; and where each ULM heteroatom is nitrogen; L is a chemical linker group represented by the formula -(AL)q-, wherein (AL)q is connected to ULM and PTM; q is 1, 2, 3 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13; each AL is independently selected from a bond, CRL1RL2, O, S, SO, SO 2, NRL3, CO, C≡C, C3-11cycloalkyl, C3-11heterocyclyl having 1 or 2 N or O atoms and optionally substituted with 1 RL1 group, and 5- or 6-membered heteroaryl having 1, 2 or 4 N atoms; and each of RL1, RL2, RL3, RL4 and RL5 independently represents H, halogen or C1-8alkyl; PTM is the structure of formula (IPTM), each XPTM is independently CH or N; indicates the place of attachment L; RPTM1 represents 1, 2 or 3 substitutions, each substitution is independently selected from OH, halogen and C1-6alkoxy; RPTM2 represents 1 or 2 substitutions, each substitution is independently selected from H, halogen, CF3, linear or branched C1-6alkyl, methoxy; RPTM3 is 1 or 2 substitutions, each substitution is independently H or halogen; and RPTM4 is H or methyl.

EFFECT: modulators of the estrogen receptor (target protein).

13 cl, 7 dwg, 544 ex

Formula (IPTM)

Similar patents RU2797244C2

Title Year Author Number
ESTROGEN RECEPTOR PROTEOLYSIS MODULATORS AND RELATED USES THEREOF 2018
  • Qian, Yimin
  • Crew, Andrew, P.
  • Crews, Craig, M.
  • Dong, Hanqing
  • Hornberger, Keith, R.
  • Wang, Jing
RU2797808C2
PROTEOLYSIS MODULATORS AND RELATED USES 2019
  • Crew, Andrew P.
  • Hornberger, Keith R.
  • Wang, Jing
  • Dong, Hanqing
  • Berlin, Michael
  • Crews, Craig M.
RU2805511C2
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF 2017
  • Crew, Andrew, P.
  • Berlin, Michael
  • Flanagan, John, J.
  • Dong, Hanqing
  • Ishchenko, Alexey
RU2805523C2
COMPOUNDS TARGETING BRM AND RELATED USES THEREOF 2019
  • Crew, Andrew P.
  • Wang, Jing
  • Berlin, Michael
  • Dragovich, Peter
  • Chen, Huifen
  • Staben, Leanna
RU2797832C2
CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM 2018
  • Crew, Andrew, P.
  • Berlin, Michael
  • Dong, Hanqing
  • Hornberger, Keith, R.
  • Qian, Yimin
  • Snyder, Lawrence, B.
  • Wang, Jing
  • Zimmermann, Kurt
RU2795146C2
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE 2017
  • Kheker, Skott
  • Reddi, Radzha K.
  • Glinka, Tomash
  • Rodni, Olga
RU2773346C2
COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS 2015
  • Phadke Avinash S.
  • Wang Xiangzhu
  • Chen Dawei
  • Hashimoto Akihiro
  • Gadhachanda Venkat Rao
  • Pais Godwin
  • Wang Qiuping
  • Agarwal Atul
  • Deshpande Milind
  • Wiles Jason Allan
RU2703995C2
MEK INHIBITORS AND THEIR THERAPEUTIC USE 2021
  • Kholl, Brett Mettyu
  • Dekorte, Bart Liven
  • King, Piter Dzhon
  • Linders, Ruben
  • Vegert, Anita
  • Fouler, Kevin
  • Kolitts, Sara
  • Dudman, Robin
  • Polakker, Yarno
  • Folmer, Rutger Khenk Adrian
RU2812929C1
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC 2005
  • Arimoto Khirokazu
  • Lu Tszjun'
  • Jamano Josinori
  • Jasukata Tatsuro
  • Josida Osamu
  • Ivaki Tsutomu
  • Josida Jutaka
  • Kato Issei
  • Morimoto Kendzi
  • Jasosima Kajo
RU2424248C2
CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION 2014
  • Gakhete Mateos Andres
  • Kastro Palomino Khulio
  • Marti Klausel Luk
  • Tormo Karulya Damiya
RU2665709C2

RU 2 797 244 C2

Authors

Kryu, Endryu, P.

Tsyan, Imin

Dun, Khantsin

Van, Tszin

Khornberger, Kejt, R.

Dates

2023-06-01Published

2017-12-01Filed